IoT-Based Emergency Vehicle Services in Intelligent Transportation System

Emergency Management System (EMS) is an important component of Intelligent transportation systems, and its primary objective is to send Emergency Vehicles (EVs) to the location of a reported incident. However, the increasing traffic in urban areas, especially during peak hours, results in the delayed arrival of EVs in many cases, which ultimately leads to higher fatality rates, increased property damage, and higher road congestion. Existing literature addressed this issue by giving higher priority to EVs while traveling to an incident place by changing traffic signals (e.g., making the signals green) on their travel path. A few works have also attempted to find the best route for an EV using traffic information (e.g., number of vehicles, flow rate, and clearance time) at the beginning of the journey. However, these works did not consider congestion or disruption faced by other non-emergency vehicles adjacent to the EV travel path. The selected travel paths are also static and do not consider changing traffic parameters while EVs are en route. To address these issues, this article proposes an Unmanned Aerial Vehicle (UAV) guided priority-based incident management system to assist EVs in obtaining a better clearance time in intersections and thus achieve a lower response time. The proposed model also considers disruption faced by other surrounding non-emergency vehicles adjacent to the EVs' travel path and selects an optimal solution by controlling the traffic signal phase time to ensure that EVs can reach the incident place on time while causing minimal disruption to other on-road vehicles. Simulation results indicate that the proposed model achieves an 8% lower response time for EVs while the clearance time surrounding the incident place is improved by 12%.

Reversible inhibitory effect of the non-steroidal antiandrogen flutamide (SCH 13521) on spermatogenesis in mice

The effects of a prolonged subcutaneous administration of SCH 13521 dissolved in 0.3% hydroxypropyl cellulose (2-8 weeks in daily doses of 0.2 or 1.0 mg amounting to an estimated equivalent of experimental and curative doses used by others in laboratory animals and men) were studied in males of the mouse inbred strain C57BL/6. Following the treatment, the activity of spermatogenesis (expressed as the mean number of seminiferous tubules containing mature sperm and epididymal sperm count) was inhibited while the testis weight was not reduced, obviously due to an absolute increase of the interstitial tissue which was a marked histological feature of the testes, particularly following the higher doses of SCH 13521. Lower doses and shorter-lasting administration of the compound seem to inhibit the activity more effectively because after a prolonged administration reparatory processes tend to be triggered via a stimulatory effect on the synthesis of testosterone in Leydig cells. The solvent alone, hydroxypropyl cellulose, had some inhibitory effect on spermatogenesis. The lymphoid system remained both morphologically and functionally unaffected by SCH 13521 unlike the steroidal antiandrogen cyproterone actetate.